• 1
    Bach FH, Fishman JA, Daniels N et al. Uncertainty in xenotransplantation: individual benefit versus collective risk. Nat Med 1998; 4: 141144.
  • 2
    Fishman JA. Xenosis and xenotransplantation: addressing the infectious risks posed by an emerging technology. Kidney Int Suppl 1997; 58: S41S45.
  • 3
    Fishman JA. Infection and xenotransplantation. Developing strategies to minimize risk. Ann N Y Acad Sci 1998; 862: 5266.
  • 4
    Fishman JA, Patience C. Xenotransplantation: infectious risk revisited. Am J Transplant 2004; 4: 13831390.
  • 5
    Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357: 26012614.
  • 6
    Mattiuzzo G, Scobie L, Takeuchi Y. Strategies to enhance the safety profile of xenotransplantation: minimizing the risk of viral zoonoses. Curr Opin Organ Transplant 2008; 13: 184188.
  • 7
    Mattiuzzo G, Takeuchi Y, Scobie L. Potential zoonotic infection of PERV in xenotransplantation. In: Rafael Manez Mendiluce CCV, ed. Xenotransplantation: Methods and Protocols. London, UK: Humana Press, 2011 (in press).
  • 8
    Mueller NJ, Takeuchi Y, Mattiuzzo G, Scobie L. Microbial safety in xenotransplantation. Curr Opin Organ Transplant 2011; 16: 201206.
  • 9
    World Health Organization. WHA57.18 Human Organ and Tissue Transplantation. World Health Organization, 2004.
  • 10
    First World Health Organization Global Consultation on Regulatory Requirements for Xenotransplantation Clinical Trials: Changsha, China, 19–21 November 2008. Xenotransplantation 2008; 16: 6163.
  • 11
    U.S. Food and Drug Administration. PHS Guideline on Infectious Disease Issues in Xenotransplantation. U.S. Food and Drug Administration, 2001.
  • 12
    U.S. Food and Drug Administation. Guidance for Industry: Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). U.S. Food and Drug Administation, 2007.
  • 13
    U.S. Food and Drug Administration. Guidance for Industry: Public Health Issues Posed by the Use of Non-Human Primate Xenografts in Humans. U.S. Food and Drug Administration, 1999.
  • 14
    U.S. Food and Drug Administration. Guidance for Industry: Source Animal, Product, Preclinical, and Clinical Issues Concerning the Use of Xenotransplantation Products in Humans. U.S. Food and Drug Administration, 2003.
  • 15
    World Health Organization. WHO Consultation on Xenotransplantation—WHO/EMC/ZOO/98.1 (Guidance Document). World Health Organization, 1997.
  • 16
    World Health Organization. OECD/WHO Consultation on Xenotransplantation Surveillance—WHO/CDS/CSR/EPH/2001.2 (Guidance Document). World Health Organization, 2000.
  • 17
    Garkavenko O, Croxson MC, Irgang M, Karlas A, Denner J, Elliott RB. Monitoring for presence of potentially xenotic viruses in recipients of pig islet xenotransplantation. J Clin Microbiol 2004; 42: 53535356.
  • 18
    Paradis K, Langford G, Long Z et al. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. Science 1999; 285: 12361241.
  • 19
    Heneine W, Tibell A, Switzer WM et al. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts [erratum appears in Lancet 1998 October 31; 352(9138): 1478]. Lancet 1998; 352: 695699.
  • 20
    Patience C, Patton GS, Takeuchi Y et al. No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys [see comments]. Lancet 1998; 352: 699701.
  • 21
    OECD/WHO. OECD/WHO Consultation on Xenotransplantation Surveillance: Summary. OECD/WHO, 2001.
  • 22
    Humar A, Fishman JA. Donor-derived infection: old problem, new solutions? Am J Transplant 2008; 8: 10871088.
  • 23
    Fishman JA, Strong DM, Kuehnert MJ. Organ and tissue safety workshop 2007: advances and challenges. Cell Tissue Bank 2009; 10: 271280.
  • 24
    Fischer SA, Graham MB, Kuehnert MJ et al. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med 2006; 354: 22352249.
  • 25
    Palacios G, Druce J, Du L et al. A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med 2008; 358: 991998.
  • 26
    Martin SI, Wilkinson R, Fishman JA. Genomic presence of recombinant porcine endogenous retrovirus in transmitting miniature swine. Virol J 2006; 3: 91.
  • 27
    Bartosch B, Weiss RA, Takeuchi Y. PCR-based cloning and immunocytological titration of infectious porcine endogenous retrovirus subgroup A and B. J Gen Virol 2002; 83: 22312240.
  • 28
    Herring C, Quinn G, Bower R et al. Mapping full-length porcine endogenous retroviruses in a large white pig. J Virol 2001; 75: 1225212265.
  • 29
    Takeuchi Y, Patience C, Magre S et al. Host range and interference studies of three classes of pig endogenous retrovirus. J Virol 1998; 72: 99869991.
  • 30
    Ericsson T, Oldmixon B, Blomberg J, Rosa M, Patience C, Andersson G. Identification of novel porcine endogenous betaretrovirus sequences in miniature swine. J Virol 2001; 75: 27652770.
  • 31
    Niebert M, Tonjes RR. Analyses of prevalence and polymorphisms of six replication-competent and chromosomally assigned porcine endogenous retroviruses in individual pigs and pig subspecies. Virology 2003; 313: 427434.
  • 32
    Akiyoshi DE, Denaro M, Zhu H, Greenstein JL, Banerjee P, Fishman JA. Identification of a full-length cDNA for an endogenous retrovirus of miniature swine. J Virol 1998; 72: 45034507.
  • 33
    Wood JC, Quinn G, Suling KM et al. Identification of exogenous forms of human-tropic porcine endogenous retrovirus in miniature Swine. J Virol 2004; 78: 24942501.
  • 34
    Patience C, Switzer WM, Takeuchi Y et al. Multiple groups of novel retroviral genomes in pigs and related species. J Virol 2001; 75: 27712775.
  • 35
    Le Tissier P, Stoye JP, Takeuchi Y, Patience C, Weiss RA. Two sets of human-tropic pig retrovirus. Nature 1997; 389: 681682.
  • 36
    Wilson CA, Wong S, Muller J, Davidson CE, Rose TM, Burd P. Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J Virol 1998; 72: 30823087.
  • 37
    Oldmixon BA, Wood JC, Ericsson TA et al. Porcine endogenous retrovirus transmission characteristics of an inbred herd of miniature swine. J Virol 2002; 76: 30453048.
  • 38
    Bartosch B, Stefanidis D, Myers R, Weiss R, Patience C, Takeuchi Y. Evidence and consequence of porcine endogenous retrovirus recombination. J Virol 2004; 78: 1388013890.
  • 39
    Scobie L, Taylor S, Wood JC et al. Absence of replication-competent human-tropic porcine endogenous retroviruses in the germ line DNA of inbred miniature Swine. J Virol 2004; 78: 25022509.
  • 40
    Wilhelm M, Fishman JA, Pontikis R, Aubertin AM, Wilhelm FX. Susceptibility of recombinant porcine endogenous retrovirus reverse transcriptase to nucleoside and non-nucleoside inhibitors. Cell Mol Life Sci 2002; 59: 21842190.
  • 41
    Qari SH, Magre S, Garcia-Lerma JG et al. Susceptibility of the porcine endogenous retrovirus to reverse transcriptase and protease inhibitors. J Virol 2001; 75: 10481053.
  • 42
    Hector RD, Meikle S, Grant L, Wilkinson RA, Fishman JA, Scobie L. Pre-screening of miniature swine may reduce the risk of transmitting human tropic recombinant porcine endogenous retroviruses. Xenotransplantation 2007; 14: 222226.
  • 43
    Archibald AL, Bolund L, Churcher C et al. Pig genome sequence—analysis and publication strategy. BMC Genomics 2010; 11: 438.
  • 44
    Garkavenko O, Wynyard S, Nathu D et al. Porcine endogenous retrovirus transmission characteristics from a designated pathogen-free herd. Transplant Proc 2008; 40: 590593.
  • 45
    Garkavenko O, Wynyard S, Nathu D et al. Porcine endogenous retrovirus (PERV) and its transmission characteristics: a study of the New Zealand designated pathogen-free herd. Cell Transplant 2008; 17: 13811388.
  • 46
    Sachs DH. Mixed chimerism as an approach to transplantation tolerance. Clin Immunol 2000; 95: S63S68.
  • 47
    Issa NC, Wilkinson RA, Griesemer A et al. Absence of replication of porcine endogenous retrovirus and porcine lymphotropic herpesvirus type 1 with prolonged pig cell microchimerism after pig-to-baboon xenotransplantation. J Virol 2008; 82: 1244112448.
  • 48
    Niebert M, Tonjes RR. Molecular cloning and functional characterization of infectious PERV and development of diagnostic tests. Curr Top Microbiol Immunol 2003; 278: 217237.
  • 49
    Tacke SJ, Bodusch K, Berg A, Denner J. Sensitive and specific immunological detection methods for porcine endogenous retroviruses applicable to experimental and clinical xenotransplantation. Xenotransplantation 2001; 8: 125135.
  • 50
    Matthews AL, Brown J, Switzer W, Folks TM, Heneine W, Sandstrom PA. Development and validation of a Western immunoblot assay for detection of antibodies to porcine endogenous retrovirus. Transplantation 1999; 67: 939943.
  • 51
    Garkavenko O, Obriadina A, Meng J et al. Detection and characterisation of swine hepatitis E virus in New Zealand. J Med Virol 2001; 65: 525529.